It was found that adding NB-UVB light therapy to ruxolitinib (Opzelura) 1.5% cream helped many vitiligo patients who did not respond early to treatment achieve faster and more noticeable skin ...

Dr Dunn leads a discussion outlining frontline therapies for the treatment of vitiligo. Jeffrey D. Dunn, PharmD, MBA: What therapies are being used? Are they generally covered by different books of ...

Experts provide closing pearls regarding the current and prospective treatment landscape of vitiligo. Jeffrey D. Dunn, PharmD, MBA: This has been an awesome discussion. Before we conclude, I’d like to ...

Vitiligo is an autoimmune disorder that leads to the loss of skin pigmentation. A recent study shows a medicated cream called ruxolitinib is extremely effective in about one-third of patients. The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Therapy using a 308 nm laser was ...

On July 18, the U.S. Food and Drug Administration (FDA) approved ruxolitinib (Opzelura) cream 1.5 percent as a treatment for the most common form of vitiligo, according to a statement by Incyte, the ...

Vitiligo is a long-term skin condition where certain areas lose their natural color and turn noticeably lighter than the ...

Last spring, Dominick was at a golf tournament with some friends watching some of the golfers on the putting green. A woman behind him made a comment about how ugly his skin was and that he probably ...

Edesa Biotech, Inc. (NASDAQ:EDSA) is planning for a Phase 2 study of its anti-CXCL10 monoclonal antibody for the treatment of moderate-to-severe non-segmental vitiligo patients. Vitiligo is a disease ...